Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire

被引:0
作者
Sieta T. de Vries
Peter G. M. Mol
Dick de Zeeuw
Flora M. Haaijer-Ruskamp
Petra Denig
机构
[1] University of Groningen,Department of Clinical Pharmacology
[2] University Medical Center Groningen,undefined
来源
Drug Safety | 2013年 / 36卷
关键词
Chronic Obstructive Pulmonary Disease; Adverse Drug Event; Recall Period; Answer Option; System Organ Class;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:765 / 777
页数:12
相关论文
共 132 条
[1]  
Meadows KA(2011)Patient-reported outcome measures: an overview Br J Community Nurs 16 146-151
[2]  
Zhu J(2011)Can we rely on patients’ reports of adverse events? Med Care 49 948-955
[3]  
Stuver SO(2002)Patient reporting of potential adverse drug reactions: a methodological study Br J Clin Pharmacol 53 318-325
[4]  
Epstein AM(2005)Patient-reported medication symptoms in primary care Arch Intern Med 165 234-240
[5]  
Jarernsiripornkul N(2009)Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes J Natl Cancer Inst 101 1624-1632
[6]  
Krska J(2008)Mix of methods is needed to identify adverse events in general practice: a prospective observational study BMC Fam Pract 9 35-156
[7]  
Capps PA(2007)Patient reporting of suspected adverse drug reactions: a review of published literature and international experience Br J Clin Pharmacol 63 148-S105
[8]  
Weingart SN(2011)A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients Health Qual Life Outcomes 9 83-261
[9]  
Gandhi TK(2007)What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health 10 S94-982
[10]  
Seger AC(2006)Brief communication: better ways to question patients about adverse medical events: a randomized, controlled trial Ann Intern Med 144 257-926